Clicky

Amgen Inc.(AMG) News

Date Title
Jul 25 Zai Lab Ltd (ZLAB) Delivers Positive Results for Potential Gastric Cancer Treatment
Jul 24 AstraZeneca Prepares Showdown With JNJ, Amgen With Phase 3 Win For Myasthenia Gravis Drug Candidate
Jul 24 Biosimilars Markets Global Forecast Report 2025-2035 | Launch of Glp-1 Biosimilars, Increasing Strategic Partnerships and Collaborations, & Growing Focus on Advanced R&D Fueling Opportunities
Jul 24 Looking Beyond Yield for the Safest Dividend Payers
Jul 24 2 Reasons to Like AMGN and 1 to Stay Skeptical
Jul 23 Rheumatoid Arthritis Therapeutics Market Forecast Report 2025-2034 | Rising Preference for Combination Therapies, and Entry of Generic Drugs Supports Expansion
Jul 23 Amgen vs. Novo Nordisk: Which Pharma Giant Is the Better Buy?
Jul 23 Amgen's (NASDAQ:AMGN) three-year earnings growth trails the 10% YoY shareholder returns
Jul 23 Do You Believe in the Growth Potential of Amgen (AMGN)?
Jul 23 Calciphylaxis Market Forecast Report 2025-2034 | Rising Incidence of Chronic Kidney Disease (CKD) and End-Stage Renal Disease (ESRD) Fueling Demand and Growth
Jul 22 Bispecific Antibodies Market Set to Surge to $163.15 Billion by 2032, Driven by a Robust 40.1% CAGR | Roche, Amgen, and Johnson & Johnson at the Forefront: AnalystView Market Insights
Jul 21 EdgeOne Medical Announces Appointment of Michael Denzer as VP, Client Relations to Further Elevate Product Innovation and Client Partnerships
Jul 21 NodThera Announces Appointment of Dr. Jyothis George as Chief Medical Officer
Jul 19 Why Amgen (AMGN) Could Be a Hidden Gem Among Dividend Pharma Stocks in 2025
Jul 18 Amgen (AMGN) Declines More Than Market: Some Information for Investors
Jul 18 HSBC Trims Amgen (AMGN) Price Target, Maintains Buy Rating
Jul 18 EBay Stock: How To Find & Own America's Greatest Opportunities
Jul 17 Can Amgen (AMGN) Keep the Earnings Surprise Streak Alive?
Jul 17 Eli Lilly vs. Merck: Which Drug Giant Appears Better Poised Today?
Jul 17 Thyroid Gland Disorders Diagnostics and Treatment Market Analysis Report 2024-2030 | Incorporation of AI and Advanced Therapeutics Fueling Opportunities